---
title: "Emcure Pharmaceuticals Ltd (EMCURE) — Share Price, Financials & Analysis"
symbol: "EMCURE"
company: "Emcure Pharmaceuticals Ltd"
canonical: "https://tapetide.com/stocks/EMCURE"
isin: "INE168P01015"
nse_symbol: "EMCURE"
bse_code: "544210"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 37135.34
generated_at: "2026-09-13T19:02:44.933Z"
---

# Emcure Pharmaceuticals Ltd (EMCURE)

Canonical page: https://tapetide.com/stocks/EMCURE

## Company

- **NSE Symbol:** EMCURE
- **BSE Code:** 544210
- **ISIN:** INE168P01015
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2024-07-10
- **CEO:** Mr. Satish Ramanlal Mehta
- **Employees:** 6731
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** emcure.com

## About

Incorporated in 1981, Emcure Pharmaceuticals 
Ltd manufactures and markets pharmaceutical products globally[1]

## Latest Price

- **Price:** ₹1978.9
- **Change:** +16.1 (+0.82%)
- **Open:** ₹1965
- **Day High:** ₹1999
- **Day Low:** ₹1948.2
- **Previous Close:** ₹1962.8
- **Volume:** 122389
- **As Of:** 2026-09-11T10:22:53+00:00

## Key Fundamentals

Observed at 2026-09-11T04:44:30.341652Z.

- **Market Cap:** ₹37135.34 Cr
- **Classification:** Smallcap
- **P/E (reported):** 36.5
- **P/E (TTM):** 37.1
- **EPS (TTM):** ₹53.34
- **EPS (reported):** ₹26.63
- **Book Value:** ₹260.95
- **Price to Book:** 7.52
- **Dividend Yield:** 0.18%
- **ROE:** 18.91%
- **ROCE:** 25.1%
- **Debt to Equity:** 0.31
- **Revenue (yearly):** ₹9335 Cr
- **Net Income:** ₹941.3 Cr
- **EBITDA:** ₹1877.2 Cr
- **52-Week High:** ₹2048
- **52-Week Low:** ₹1260
- **RSI (14):** 62.62

## Tapetide Score

- **Score:** 55 / 100
- **Score date:** 2026-09-04
- **Archetype:** Cheap but Weak
- **What it means:** A low multiple sitting on weak financials. Worth establishing what the market is discounting before treating the low valuation as an opportunity — weak fundamentals often justify it.
- **Pillar profile:** Quality: Weak · Valuation: Cheap · Momentum: Flat
- **Percentile:** 70.1 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 40.98 | 9% |
| growth | 51.94 | 9% |
| momentum | 59.91 | 12% |
| ownership | 60.62 | 24% |
| quality | 48.03 | 22% |
| valuation | 60.57 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 7.58 times its book value

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 10.78% | -14.01% | 22.82% |
| ebitda margin growth | 8.26% | 3.93% | 4.96% | -14.57% |
| net income growth | 20.02% | 33.05% | 21% | 18% |
| revenue growth | 3.97% | 17.14% | 15% | 13% |
| roce | 9.67% | 21.73% | 19.64% | 26.01% |
| roe | 20% | 24.08% | 17.02% | -43.09% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 1663 | 1668 | 1771 | 1815 | 2002 | 1963 | 2116 | 2101 | 2270 | 2363 | 2470 | 2580 |
| Expenses | 1334 | 1374 | 1460 | 1479 | 1621 | 1608 | 1714 | 1684 | 1794 | 1871 | 1990 | 2048 |
| Operating Profit | 329 | 294 | 311 | 336 | 381 | 355 | 402 | 417 | 475 | 493 | 480 | 532 |
| OPM % | 20 | 18 | 18 | 19 | 19 | 18 | 19 | 20 | 21 | 21 | 19 | 21 |
| Other Income | -2 | 22 | 12 | 23 | 36 | 4 | -6 | 0 | 3 | -36 | 14 | 2 |
| Interest | 59 | 61 | 65 | 59 | 46 | 32 | 39 | 27 | 33 | 38 | 46 | 32 |
| Depreciation | 70 | 84 | 91 | 94 | 97 | 97 | 97 | 99 | 105 | 105 | 106 | 110 |
| Profit before tax | 198 | 171 | 167 | 207 | 273 | 230 | 261 | 291 | 341 | 314 | 341 | 394 |
| Tax % | 26 | 30 | 27 | 26 | 26 | 32 | 24 | 26 | 26 | 26 | 29 | 26 |
| Net Profit | 146 | 120 | 121 | 153 | 202 | 156 | 197 | 215 | 251 | 231 | 244 | 292 |
| EPS in Rs | 7.69 | 6.27 | 6.36 | 7.95 | 10.29 | 8.11 | 9.97 | 10.92 | 12.84 | 12.16 | 12.84 | 15.5 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4717 | 5049 | 5033 | 5855 | 5986 | 6658 | 7896 | 9204 | 9683 |
| Expenses | 3968 | 4340 | 3817 | 4525 | 4804 | 5429 | 6427 | 7458 | 7703 |
| Operating Profit | 749 | 708 | 1216 | 1330 | 1182 | 1230 | 1469 | 1746 | 1980 |
| OPM % | 16 | 14 | 24 | 23 | 20 | 18 | 19 | 19 | 20 |
| Other Income | 72 | -25 | -159 | 63 | 39 | 47 | 62 | 100 | -17 |
| Interest | 223 | 257 | 155 | 176 | 214 | 237 | 176 | 144 | 148 |
| Depreciation | 267 | 321 | 250 | 245 | 260 | 312 | 384 | 415 | 425 |
| Profit before tax | 331 | 105 | 652 | 973 | 747 | 727 | 971 | 1287 | 1390 |
| Tax % | 37 | 4 | 36 | 28 | 25 | 27 | 27 | 27 | — |
| Net Profit | 209 | 101 | 419 | 703 | 562 | 528 | 707 | 941 | 1019 |
| EPS in Rs | 10.79 | 4.62 | 23.15 | 36.62 | 29.42 | 27.5 | 35.96 | 48.76 | 53.34 |
| Dividend Payout % | 32 | 54 | 4 | 8 | 7 | 7 | 8 | 7 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 181 | 181 | 181 | 181 | 181 | 181 | 189 | 190 |
| Reserves | 1654 | 1731 | 2092 | 1807 | 2320 | 2771 | 4257 | 4760 |
| Borrowings | 2128 | 2327 | 2310 | 2217 | 2334 | 2335 | 1023 | 1521 |
| Other Liabilities | 1613 | 1721 | 2184 | 1816 | 1798 | 2422 | 2653 | 3043 |
| Total Liabilities | 5577 | 5960 | 6768 | 6021 | 6634 | 7709 | 8122 | 9514 |
| Fixed Assets | 2247 | 2382 | 2188 | 2044 | 2147 | 3125 | 3197 | 3319 |
| CWIP | 581 | 485 | 302 | 320 | 411 | 159 | 177 | 273 |
| Investments | 0 | 0 | 0 | 25 | 25 | 318 | 95 | 20 |
| Other Assets | 2749 | 3093 | 4278 | 3632 | 4050 | 4108 | 4652 | 5903 |
| Total Assets | 5577 | 5960 | 6768 | 6021 | 6634 | 7709 | 8122 | 9514 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 444 | 500 | 704 | 768 | 747 | 1097 | 852 | 944 |
| Cash from Investing Activity | -409 | -168 | -256 | -574 | -468 | -715 | -96 | -1175 |
| Cash from Financing Activity | -735 | -301 | -189 | -152 | -145 | -164 | -814 | 343 |
| Net Cash Flow | -700 | 32 | 259 | 42 | 134 | 219 | -58 | 112 |
| Free Cash Flow | 39 | 362 | 571 | 349 | 345 | 801 | 475 | 400 |
| CFO/OP | 77 | 84 | 74 | 81 | 80 | 107 | 75 | 75 |

### Ratios

| Item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 75 | 83 | 107 | 82 | 101 | 102 | 93 | 102 |
| Inventory Days | 234 | 211 | 293 | 237 | 223 | 225 | 224 | 239 |
| Days Payable | 142 | 133 | 188 | 184 | 175 | 193 | 172 | 180 |
| Cash Conversion Cycle | 167 | 161 | 212 | 135 | 148 | 134 | 145 | 161 |
| Working Capital Days | -15 | -28 | -16 | 9 | 22 | 28 | 76 | 62 |
| ROCE % | — | 11 | 22 | 26 | 21 | 19 | 20 | 24 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 78.08% | 77.94% | 77.92% | 77.91% | 77.88% | 77.87% | 77.87% | 77.83% |
| FIIs | 2.91% | 3.05% | 3.07% | 2.86% | 3.29% | 3.59% | 3.35% | 4.88% |
| DIIs | 3.96% | 3.87% | 3.44% | 2.84% | 4.37% | 6.1% | 6.1% | 8.46% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 5% | 5.14% | 5.51% | 5.95% | 6.24% | 6.46% | 6.46% | 6.45% |
| Others | 10.04% | 10% | 10.06% | 10.44% | 8.22% | 5.98% | 6.22% | 2.38% |
| No. of Shareholders | 152914 | 143449 | 139671 | 133549 | 126169 | 118863 | 122189 | 124991 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 5 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1905.06 | Buy |
| EMA (10) | 1921.85 | Buy |
| SMA (20) | 1887.25 | Buy |
| EMA (20) | 1908.49 | Buy |
| SMA (50) | 1892.41 | Buy |
| EMA (50) | 1878.72 | Buy |
| SMA (100) | 1808.53 | Buy |
| EMA (100) | 1806.61 | Buy |
| SMA (200) | 1646.71 | Buy |
| EMA (200) | 1676.39 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 64.81 | Neutral |
| MACD (12,26,9) | 13.07 | Buy |
| Stochastic (14,3,3) | 79 | Neutral |
| ADX (14) | 19.26 | Neutral |
| Williams %R (14) | -11.9 | Sell |
| ATR (14) | 51.13 | Neutral |
| ROC (12) | 6.26 | Buy |
| Stoch RSI (14) | 100 | Sell |
| UO (7,14,28) | 52.94 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 7 | 87.5% |
| Hold | 1 | 12.5% |
| Sell | 0 | 0% |

Based on 8 analyst ratings, observed at 2026-09-11T04:44:30.364296+00:00.

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Emcure shared Q4/FY26 results: revenue Rs9,204 crore, EBITDA margin 19.4%, FY27 growth guidance low-mid teens. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 9h - Emcure shared Q4/FY26 results: revenue Rs9,204 crore, EBITDA margin 19.4%, FY27 growth guidance low-mid teens.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4f1abb03-c58e-4e1f-a940-1226258e5c51.pdf) |
| 9 Mar - Appointed C S Muralidharan as independent director effective April 1, 2026; three-year term; postal ballot for approval. | [Board Meeting Outcome for Outcome Of Board Meeting Held On March 09, 2026. 9 Mar - Appointed C S Muralidharan as independent director effective April 1, 2026; three-year term; postal ballot for approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/809d1b7d-5711-49f2-90fc-7efa35ab9409.pdf) |
| 9 Mar - Appointed C S Muralidharan as Independent Director effective April 1, 2026 for three-year term, subject to shareholder approval. | [Announcement under Regulation 30 (LODR)-Change in Management 9 Mar - Appointed C S Muralidharan as Independent Director effective April 1, 2026 for three-year term, subject to shareholder approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/cf2d7c96-7ddb-411d-bfaf-5638f8a110e1.pdf) |
| 8h - Emcure to host Q4 FY26 earnings call on May 5, 2026, for audited financial results discussion. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 8h - Emcure to host Q4 FY26 earnings call on May 5, 2026, for audited financial results discussion.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a98df309-712a-422a-ba1e-8ad1f60c0df7.pdf) |
| 8h - Board meets May 5, 2026 to approve FY26 audited results and consider final dividend. | [Board Meeting Intimation for Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31, 2026 8h - Board meets May 5, 2026 to approve FY26 audited results and consider final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/dbf3f70f-bd5a-450b-8449-fa5f7b2dcf16.pdf) |
| 8 May - NSE Sustainability Ratings assigned Emcure an ESG rating of 21 for FY2024-25. | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations, 2015 - ESG Rating 8 May - NSE Sustainability Ratings assigned Emcure an ESG rating of 21 for FY2024-25.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/88b021a5-25ae-4ab1-841a-98e13d9e2ced.pdf) |
| 7h - Postal ballot approved appointment of Mr. C S Muralidharan as Independent Director, effective April 24, 2026. | [Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 7h - Postal ballot approved appointment of Mr. C S Muralidharan as Independent Director, effective April 24, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/433e5e5c-e95d-458e-9452-adea880c6fc1.pdf) |
| 7h - Members approved Mr. C S Muralidharan as Independent Director for three years from April 1, 2026. | [Intimation Under Regulation 30 Of The SEBI (LODR) Regulations 2015 - Update On Appointment Of Independent Director 7h - Members approved Mr. C S Muralidharan as Independent Director for three years from April 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/e0432cad-ecea-45f2-add5-08f983435f89.pdf) |
| 7 Apr - Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 7 Apr - Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b48c536-dbd1-430d-9be7-83ae587fa900.pdf) |
| 6 May - Newspaper Publication of Audited Financial Results of the Company for the quarter and year ended March 31, 2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 May - Newspaper Publication of Audited Financial Results of the Company for the quarter and year ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/a1074ba1-2a88-4203-9582-3dceb69b15c6.pdf) |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Credit Rating](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1350f7b-6a81-4a17-9e45-42258063d547.pdf) |
| 2026-09-01 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b33e969-eb78-4e65-8701-89168801429e.pdf) |
| 2026-09-01 | [Intimation Under Regulations 30 And 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18ec3adc-4a14-48c1-9b30-0ba93a389a9b.pdf) |
| 2026-08-29 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=361ffc01-c587-406f-971f-6ade8c2c1466.pdf) |
| 2026-08-28 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0cc76dbe-0609-4d8c-b2ea-ef15affd0b7e.pdf) |
| 2026-08-28 | [Notice Of The 45Th Annual General Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b3cba8b5-399e-4e57-bfb1-4078cffac03e.pdf) |
| 2026-08-28 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f9cf010-aaab-4165-8ce9-1f1d73e4bf91.pdf) |
| 2026-08-25 | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d5dbb3c-b68d-4a97-b20f-a48f953c6197.pdf) |
| 2026-08-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49972f72-3546-498b-8854-1cabd4c7101a.pdf) |
| 2026-08-08 | [Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b710f3a-c259-49f3-909f-cfed62d9a105.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-06 | [Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=332f4063-3a54-403e-ad92-2fa1d3c0c271.pdf) |
| 2026-05-05 | [Financial Results (Standalone And Consolidated) For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1606bcc-42fd-401e-8072-1a587bab80fd.pdf) |
| 2026-02-04 | [Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9b03194-f3ef-4604-827f-b9a8a963fd5d.pdf) |
| 2025-11-11 | [Unaudited Financial Results For The Quarter And Half-Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d0d8415-d775-41fe-aae8-92053a1ecac1.pdf) |
| 2025-08-07 | [Outcome Of The Board Meeting Held On August 07 2025 To Approve The Unaudited Financial Results (Consolidated And Standalone) For The Quarter Ended June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a1385be-7335-4286-b3ed-f75dcf89f7e2.pdf) |
| 2025-05-22 | [Audited Financial Results For The Quarter And Year Ended March 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=309bfcf3-0319-4369-8c8e-8e5cd874ed98.pdf) |
| 2025-02-06 | [Unaudited Financial Results (Consolidated And Standalone) For The Quarter And Nine Months Ended December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d46a6a1e-f799-45eb-bb40-a9679165f9d8.pdf) |
| 2024-11-07 | [Results - Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=022ed7d1-8856-41da-be40-18822b7dcd79.pdf) |
| 2024-08-13 | [Outcome Of Board Meeting Held On August 13, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a5fffcca-b928-42b4-82d0-64a9a7dc519f.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7833750a-e706-4967-bab9-46246c99ef42.pdf) |
| 2026-06-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f5d21335-d41e-45b4-8a8d-835eb4319d49.pdf) |
| 2026-05-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7ad166a8-568d-4fd4-94f0-7ec8a5498aae.pdf) |
| 2026-02-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=138b3053-0954-4056-b45a-a77eeece8604.pdf) |
| 2025-11-19 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d68fbde8-815b-4168-9eed-97c965b6ad1a.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49e06a4d-fd64-4e18-8acc-e5ae5b372497.pdf) |
| 2026-05-05 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcb12978-12a7-4ab8-ae85-3a315f13229e.pdf) |
| 2026-02-04 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a546f43f-c112-4188-b852-4c7458bd922a.pdf) |
| 2025-11-11 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11e0261d-7369-44fe-be09-84088a2c6bbf.pdf) |
| 2025-08-07 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=241e7714-1290-4057-aa22-7a33144873d2.pdf) |
| 2025-05-22 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f17d4c1a-498c-4030-8ca8-09a9505b8448.pdf) |
| 2024-11-08 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=14d4f1d4-b3e2-4e0a-8f9c-2945675bf3f6.pdf) |
| 2024-10-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a2cebbdd-4a59-40ba-9a7c-5fac707f1f34.pdf) |
| 2024-08-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c481e23-913f-4cf7-a784-2b599197141e.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/615067f0-f75b-4b11-918e-e8edfd924ae8.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6265d94f-e2f0-44d4-a79e-83887697f462.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4f1abb03-c58e-4e1f-a940-1226258e5c51.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1b44febc-6ee7-4bd6-88cb-46a4faedbb39.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/735f829e-c6b6-4fea-ba4f-01770bcd3566.pdf) |
| Feb 2025 | [Concall - Feb 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8e7ff1a5-c6ae-490a-a58a-d9d512129ebd.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e4ed26ca-76ef-422a-a01e-753ea63ac0ac.pdf) |
| Aug 2024 | [Concall - Aug 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/359c6789-0a69-4e2d-a8fb-5bd840334030.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-02-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=735f829e-c6b6-4fea-ba4f-01770bcd3566.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=615067f0-f75b-4b11-918e-e8edfd924ae8.pdf) |
| 2025-08-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4ed26ca-76ef-422a-a01e-753ea63ac0ac.pdf) |
| 2025-05-28 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b44febc-6ee7-4bd6-88cb-46a4faedbb39.pdf) |
| 2025-02-11 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e7ff1a5-c6ae-490a-a58a-d9d512129ebd.pdf) |
| 2024-11-13 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6265d94f-e2f0-44d4-a79e-83887697f462.pdf) |
| 2024-08-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=359c6789-0a69-4e2d-a8fb-5bd840334030.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4fa3f6b5-6c40-45ed-8a66-ad9c4336d473.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:02:44.933Z.